Company / Working Capital per Share
UroGen Pharma Ltd. Working Capital per Share History
FY2017-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital per Share
$3.31
FY2025
5-year range
$3.31 / $7.08
FY2021-FY2025
Trend
-53.3%
vs FY2024
Sector context
#131 of 210
Health Care
What the data says
At $3.31, UroGen Pharma Ltd.'s working capital per share ranks #131 of 210 in the Health Care sector. Working Capital per Share has fluctuated over the past 9 years, ranging from $3.31 in FY2025 to $7.97 in FY2019.
Based on SEC 10-K filings.
3.31 in FY2025 with a 5-year CAGR of -5.9%.
Declined from $5.97 to $3.31 over the past 2 years.
Health Care sector context is included.
Working Capital per Share over time
Growth rates
- 3-Year CAGR
- -10.9%
- 5-Year CAGR
- -5.9%
- 10-Year CAGR
- -
Sector benchmark
#131 of 210 in Health CareTop 62% of 210This company $3.31 Sector average $146.86
▼
-97.7% below sector average
Key checks
Key Insights
- In FY2025, working capital per share decreased 53.3% year-over-year.
- Ranks #131 out of 210 companies in the Health Care sector.
- Peak working capital per share was recorded in FY2019.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -5.09 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Working Capital per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $3.31 | -53.3% |
| FY2024 | $7.08 | +18.8% |
| FY2023 | $5.97 | +27.6% |
| FY2022 | $4.67 | +12.6% |
| FY2021 | $4.15 | -7.3% |
| FY2020 | $4.48 | -43.8% |
| FY2019 | $7.97 | +23.4% |
| FY2018 | $6.46 | -7.0% |
| FY2017 | $6.94 | - |
| FY2016 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026